Post-marketing, prospective, multicentric, non-randomized registry to evaluate the safety and efficacy of Inspiron Sirolimus Eluting Coronary Stent at the treatment of "real-world" patients.
Up to 5.0000 patients with native coronary arteries lesions with diameter between 2.5 and 4.0 mm and 34 mm of length treated solely with the Inspiron Sirolimus Eluting Coronary Stent. Stent implantation should be performed according to the Instructions for Use and according to the local practice. It is recommended that ECG and cardiac enzymes are collected before and after procedure. Dual anti-platelet therapy is recommended for at least 6 months after procedure. Patients will be followed at 30 days, 1 and 2 years after procedure.
Study Type
OBSERVATIONAL
Enrollment
2,504
coronary stent implantation
União Brasileira de Educação e Assistência - Hospital São Lucas da PUC - RS
Porto Alegre, Rio Grande do Sul, Brazil
Major Adverse Cardiac Events Rate
Cardiac Death, MI, Target Lesion Revascularization and Stent Thrombosis
Time frame: 12 months
Target Vessel and Lesion Revascularization Rates
Target Vessel and Lesion Revascularization
Time frame: 24 months
Stent Thrombosis Rate
Stent Thrombosis
Time frame: 24 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.